Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Spiroindane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106365949A reveals a breakthrough in chiral spiroindane synthesis, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel TiCl4-catalyzed asymmetric cyclization for high-purity spiroindane intermediates. Eliminates resolution steps, ensuring cost-effective supply for chiral ligand manufacturing.
Patent CN116041207A reveals a novel chiral spiroindane ligand enabling high-selectivity C-H activation. Discover cost-effective synthesis and supply chain advantages.